Orion OYJ (OTCMKTS:ORINY) Releases Earnings Results

Orion OYJ (OTCMKTS:ORINY) posted its quarterly earnings results on Thursday. The company reported $1.08 earnings per share (EPS) for the quarter, Zacks reports. Orion OYJ had a net margin of 19.33% and a return on equity of 31.36%. The company had revenue of $809.41 million for the quarter.

Orion OYJ Price Performance

Shares of OTCMKTS:ORINY opened at $40.61 on Friday. The firm’s 50 day moving average is $37.44 and its two-hundred day moving average is $37.61. The firm has a market capitalization of $11.46 billion, a P/E ratio of 32.75 and a beta of 0.04. The company has a current ratio of 1.99, a quick ratio of 1.19 and a debt-to-equity ratio of 0.13. Orion OYJ has a 52 week low of $25.95 and a 52 week high of $42.75.

Wall Street Analysts Forecast Growth

Separately, Danske cut shares of Orion OYJ from a “buy” rating to a “hold” rating in a report on Thursday, January 15th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Orion OYJ currently has an average rating of “Hold”.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.